☆ 4.6 Letter

Production of 2-hydroxyglutarate by isocitrate dehydrogenase 1-mutated gliomas: an evolutionary alternative to the Warburg shift?

NEURO-ONCOLOGY (2011)

期刊

NEURO-ONCOLOGY

卷 13, 期 12, 页码 1262-1264

出版社

OXFORD UNIV PRESS INC

DOI: 10.1093/neuonc/nor083

关键词

-

类别

Oncology Clinical Neurology

资金

NINDS NIH HHS [R01 NS060752, R01 NS066955] Funding Source: Medline

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Review Oncology

Mutant IDH in Gliomas: Role in Cancer and Treatment Options

Georgios Solomou, Alina Finch, Asim Asghar, Chiara Bardella

Summary: Altered metabolism is observed in many cancers, including gliomas, due to mutations in metabolic genes like isocitrate dehydrogenase (IDH). Mutant IDH converts α-ketoglutarate (α-KG) to D2-hydroxyglutarate (D2-HG) instead of isocitrate. Accumulation of D2-HG in IDH mutant tumors has led to the development of small inhibitors to target mutant IDH. This review summarizes the cellular and molecular consequences of IDH mutations and therapeutic approaches for IDH mutant tumors, with a focus on gliomas.

CANCERS (2023)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Preoperative Determination of Isocitrate Dehydrogenase Mutation in Gliomas Using Spectral EditingMRS: A Prospective Study

Thanh B. Nguyen, Gerd Melkus, Michael Taccone, Ioana D. Moldovan, Diana Ghinda, Ryan Gotfrit, Carlos H. Torres, Nader Zakhari, Santanu Chakraborty, John Woulfe, Gerard Jansen, Matthew DF. McInnes, Rebecca E. Thornhill, Ian Cameron, Fahad AlKherayf

Summary: This study prospectively evaluated the diagnostic accuracy of edited MRS in predicting the IDH mutation status in patients with gliomas. The results suggest that preoperative edited MRS can help identify IDH-mutant gliomas with high specificity.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2021)

添加到收藏夹

Article Oncology

Non-Invasive Assessment of Isocitrate Dehydrogenase-Mutant Gliomas Using Optimized Proton Magnetic Resonance Spectroscopy on a Routine Clinical 3-Tesla MRI

Laiz Laura de Godoy, Kheng Choon Lim, Archith Rajan, Gaurav Verma, Mauro Hanaoka, Donald M. O'Rourke, John Y. K. Lee, Arati Desai, Sanjeev Chawla, Suyash Mohan

Summary: The purpose of this study was to investigate the clinical potential of proton MR spectroscopy (H-1-MRS) in identifying IDH-mutant gliomas. The study found that the detection of 2HG and its complex interaction with other metabolites can accurately identify IDH-mutant gliomas.

CANCERS (2023)

添加到收藏夹

Article Oncology

Hyperthermia as a Potential Cornerstone of Effective Multimodality Treatment with Radiotherapy, Cisplatin and PARP Inhibitor in IDH1-Mutated Cancer Cells

Mohammed Khurshed, Elia Prades-Sagarra, Sarah Saleh, Peter Sminia, Johanna W. Wilmink, Remco J. Molenaar, Hans Crezee, Cornelis J. F. van Noorden

Summary: Mutations in the IDH1(MUT) gene are causal in the development and progression of various malignancies. Hyperthermia can sensitize IDH1(MUT) cancer cells to radiation and chemotherapy, providing a new approach for the treatment of these tumors.

CANCERS (2022)

添加到收藏夹

Article Oncology

The diagnostic value of lower glucose consumption for IDH1 mutated gliomas on FDG-PET

Feng-Min Liu, Yu-Fei Gao, Yanyan Kong, Yihui Guan, Jinsen Zhang, Shuai-Hong Li, Dan Ye, Wenyu Wen, Chuantao Zuo, Wei Hua

Summary: The SUVmax on PET can predict IDH1 mutation with high sensitivity and specificity, supported by reduced glucose consumption in IDH1 mutant gliomas, as evidenced by changes in glucose quantity and metabolic enzyme expression levels.

BMC CANCER (2021)

添加到收藏夹

Review Cell Biology

The Roles of 2-Hydroxyglutarate

Xin Du, Hai Hu

Summary: 2-HG plays a significant role in 2-hydroxyglutaric aciduria, tumors with IDH1/2mt mutations, and ccRCC, being regarded as an oncometabolite. It can also accumulate in hypoxic or acidic pH conditions, and has been shown to have a vital role in the fate decision of immune cells.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

添加到收藏夹

Article Hematology

Prognostic significance of concurrent gene mutations i n intensively treated patients with IDH-mutated AML: an ALFA study

Matthieu Duchmann, Jean-Baptiste Micol, Nicolas Duployez, Emmanuel Raffoux, Xavier Thomas, Jean-Pierre Marolleau, Thorsten Braun, Lionel Ades, Sylvain Chantepie, Emilie Lemasle, Celine Berthon, Jean-Valere Malfuson, Cecile Pautas, Juliette Lambert, Nicolas Boissel, Karine Celli-Lebras, Denis Caillot, Pascal Turlure, Norbert Vey, Arnaud Pigneux, Christian Recher, Christine Terre, Claude Gardin, Raphael Itzykson, Claude Preudhomme, Herve Dombret, Stephane de Botton

Summary: This study analyzed the prognostic impact of co-occurring genetic alterations and HSCT in AML patients with IDH mutations treated with IC. NPM1 mutations were found to be associated with improved overall survival in different IDH subgroups. HSCT was shown to have a positive impact on the outcomes of nonfavorable IDH1/2-mutated AML patients.

BLOOD (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Mutated Isocitrate Dehydrogenase (mIDH) as Target for PET Imaging in Gliomas

Felix Neumaier, Boris D. D. Zlatopolskiy, Bernd B. Neumaier

Summary: In this review titled "Prospects and challenges for the application of mutated IDH PET probes in gliomas", the authors summarize the rationale behind the development of mutated IDH PET probes, describe their potential applications beyond IDH status assessment, and highlight potential challenges in tracer development. The authors also compile the major chemical classes of mutated IDH-selective inhibitors that have been described to date, briefly consider possible strategies for radiolabeling of the most promising candidates, and assess the suitability of radiolabeled analogs of mutated IDH inhibitors for PET imaging in gliomas.

MOLECULES (2023)

添加到收藏夹

Review Immunology

Advances in Immune Microenvironment and Immunotherapy of Isocitrate Dehydrogenase Mutated Glioma

Dongming Yan, Weicheng Li, Qibing Liu, Kun Yang

Summary: The tumor immune microenvironment and immunotherapy in IDH-mutant gliomas have been extensively studied. IDH mutations inhibit immune evasion and T-cell responses, making it a potential target for immunotherapy.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Review Clinical Neurology

Targeting IDH1/IDH2 mutations in gliomas

Macarena I. de la Fuente

Summary: Somatic mutations in IDH are commonly found in gliomas and play a key role in gliomagenesis. Various experimental therapeutic approaches, including direct inhibitors, immunotherapies, and epigenetic/metabolic drugs, have shown promising results. Ongoing studies aim to elucidate the precise role of these treatments and the optimal timing for their application.

CURRENT OPINION IN NEUROLOGY (2022)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Development of a 2-hydroxyglutarate production system by Corynebacterium glutamicum

Naoya Kataoka, Kazunobu Matsushita, Toshiharu Yakushi

Summary: In this study, a system for efficient production of 2-HG was developed using Corynebacterium glutamicum. The hgdH gene from Acidaminococcus fermentans was introduced into C. glutamicum, resulting in the biosynthesis of 2-OG. The engineered strain produced the highest reported titer and yield of 2-HG thus far under biotin- and nitrogen-limited conditions.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2023)

添加到收藏夹

Review Oncology

IDH Mutations in Chondrosarcoma: Case Closed or Not?

Sanne Venneker, Judith V. M. G. Bovee

Summary: Chondrosarcomas frequently carry isocitrate dehydrogenase (IDH) gene mutations and these mutations play a significant role in early stages of cartilage tumour development. However, their role in later stages remains unclear. Other types of IDH mutant tumours have shown the impact of this mutation on patient outcomes and therapies. Factors such as tumour type, elevated oncometabolite levels, the type of model used in preclinical studies, and additional (epi)genetic alterations could explain the discrepancy in the role of IDH mutations. Recent studies have identified subgroups within IDH wildtype and mutant chondrosarcomas, which should be further studied to improve treatment and predictive biomarkers.

CANCERS (2023)

添加到收藏夹

Review Oncology

DNA damage in IDH-mutant gliomas: mechanisms and clinical implications

Diana D. Shi, Soummitra Anand, Kalil G. Abdullah, Samuel K. McBrayer

Summary: This article summarizes the current understanding of how IDH mutations influence DNA damage in glioma and discusses the clinical implications of these findings.

JOURNAL OF NEURO-ONCOLOGY (2023)

添加到收藏夹

Article Oncology

A phase 1 study of IDH305 in patients with IDH1R132-mutant acute myeloid leukemia or myelodysplastic syndrome

Courtney D. DiNardo, Andreas Hochhaus, Mark G. Frattini, Karen Yee, Thomas Zander, Alwin Kraemer, Xueying Chen, Yan Ji, Nehal S. Parikh, Joanne Choi, Andrew H. Wei

Summary: This study aimed to determine the recommended dose for IDH305 in patients with IDH1(R132)-mutant AML and MDS. The results showed acceptable pharmacokinetic characteristics of IDH305 in patients, and demonstrated target engagement. Although adverse events were reported, hepatotoxicity could be managed through dose modification.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Coordinatized lesion location analysis empowering ROI-based radiomics diagnosis on brain gliomas

Xiaoxue Liu, Qirui Zhang, Jianrui Li, Qiang Xu, Zhizheng Zhuo, Junjie Li, Xian Zhou, Mengjie Lu, Qingqing Zhou, Hao Pan, Nan Wu, Qing Zhou, Feng Shi, Guangming Lu, Yaou Liu, Zhiqiang Zhang

Summary: This study aimed to evaluate the efficacy of coordinatized lesion location analysis (CLLA) in improving the accuracy and generalization of ROI-based radiomics diagnosis of gliomas. A fusion location-radiomics model was constructed based on CLLA and ROI-based radiomic analyses, which showed better diagnostic accuracy and generalization compared to other models.

EUROPEAN RADIOLOGY (2023)

添加到收藏夹

Article Oncology

IgA-Dominated Humoral Immune Responses Govern Patients' Outcome in Endometrial Cancer

Gunjan Mandal, Subir Biswas, Carmen M. Anadon, Xiaoqing Yu, Chandler D. Gatenbee, Sandhya Prabhakaran, Kyle K. Payne, Ricardo A. Chaurio, Alexandra Martin, Patrick Innamarato, Carlos Moran, John J. Powers, Carly M. Harro, Jessica A. Mine, Kimberly B. Sprenger, Kristen E. Rigolizzo, Xuefeng Wang, Tyler J. Curiel, Paulo C. Rodriguez, Alexander R. Anderson, Ozlen Saglam, Jose R. Conejo-Garcia

Summary: This study reveals the crucial role of humoral immunity in human endometrial cancer and provides insights for the development of novel immunotherapies against this prevalent malignancy. Coordinated cellular and humoral immune responses, particularly involving B cells and IgA:plgR interactions, determine the progression of endometrial cancer and its response to treatment.

CANCER RESEARCH (2022)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Fluctuating methylation clocks for cell lineage tracing at high temporal resolution in human tissues

Calum Gabbutt, Ryan O. Schenck, Daniel J. Weisenberger, Christopher Kimberley, Alison Berner, Jacob Househam, Eszter Lakatos, Mark Robertson-Tessi, Isabel Martin, Roshani Patel, Susan K. Clark, Andrew Latchford, Chris P. Barnes, Simon J. Leedham, Alexander R. A. Anderson, Trevor A. Graham, Darryl Shibata

Summary: Lineage tracing of human stem cells can be achieved by measuring fluctuating DNA methylation, which can serve as clocks that record cell ancestry. This study developed a mathematical model to quantitatively measure the dynamics of human adult stem cells using fluctuating DNA methylation marks. The results showed differences in the number and replacement speed of stem cells in different tissues, and also demonstrated the potential application of fluctuating methylation clocks in diseases.

NATURE BIOTECHNOLOGY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Roadmap on plasticity and epigenetics in cancer

Jasmine Foo, David Basanta, Russell C. Rockne, Carly Strelez, Curran Shah, Kimya Ghaffarian, Shannon M. Mumenthaler, Kelly Mitchell, Justin D. Lathia, David Frankhouser, Sergio Branciamore, Ya-Huei Kuo, Guido Marcucci, Robert Vander Velde, Andriy Marusyk, Sui Huang, Kishore Hari, Mohit Kumar Jolly, Haralampos Hatzikirou, Kamrine E. Poels, Mary E. Spilker, Blerta Shtylla, Mark Robertson-Tessi, Alexander R. A. Anderson

Summary: This article focuses on the role of plasticity and epigenetics in cancer, and discusses state-of-the-art mathematical and experimental approaches to study these aspects. It addresses important questions about the integration of non-genetic plasticity and mutation-driven somatic evolution, the measurement and modeling of the microenvironment's role, experimental study of non-genetic plasticity, suitable mathematical techniques, as well as the clinical and practical applications and implications.

PHYSICAL BIOLOGY (2022)

添加到收藏夹

Article Oncology

Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells

Carmen M. Anadon, Xiaoqing Yu, Kay Hanggi, Subir Biswas, Ricardo A. Chaurio, Alexandra Martin, Kyle K. Payne, Gunjan Mandal, Patrick Innamarato, Carly M. Harro, Jessica A. Mine, Kimberly B. Sprenger, Carla Cortina, John J. Powers, Tara Lee Costich, Bradford A. Perez, Chandler D. Gatenbee, Sandhya Prabhakaran, Douglas Marchion, Mirjam H. M. Heemskerk, Tyler J. Curiel, Alexander R. Anderson, Robert M. Wenham, Paulo C. Rodriguez, Jose R. Conejo-Garcia

Summary: This study reveals that tissue-resident memory (TRM) cells are the main type of T cells infiltrating ovarian cancer. These TRM cells, specifically the progenitor TRMstem cells, play a crucial role in predicting the outcome of ovarian cancer. The findings suggest that ovarian cancer is immunogenic, but only a small portion of tumor-infiltrating T cells have tumor antigen reactivity.

CANCER CELL (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Gattaca: Base-Pair Resolution Mutation Tracking for Somatic Evolution Studies using Agent-based Models

Ryan O. Schenck, Gabriel Brosula, Jeffrey West, Simon Leedham, Darryl Shibata, Alexander R. A. Anderson

Summary: Research in the past two decades has significantly advanced our understanding of somatic mutations, particularly in homeostatic tissue. The emergence of agent-based mechanistic models has provided a valuable tool for studying somatic mutations at base-pair resolution, with Gattaca being introduced as the first method for this purpose. By incorporating human reference genomes, mutational context, and sequence coverage/error information, Gattaca allows for realistic evolution of sequence data for comparison between in silico cell tissue modeling and experimental human somatic mutation data.

MOLECULAR BIOLOGY AND EVOLUTION (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Immunosuppressive niche engineering at the onset of human colorectal cancer

Chandler D. Gatenbee, Ann-Marie Baker, Ryan O. Schenck, Maximilian Strobl, Jeffrey West, Margarida P. Neves, Sara Yakub Hasan, Eszter Lakatos, Pierre Martinez, William C. H. Cross, Marnix Jansen, Manuel Rodriguez-Justo, Christopher J. Whelan, Andrea Sottoriva, Simon Leedham, Mark Robertson-Tessi, Trevor A. Graham, Alexander R. A. Anderson

Summary: Integration of mathematical modeling, ecological analyses, and neoantigen prediction suggests that recruitment of immunosuppressive cells is crucial for the transformation from adenoma to carcinoma in colorectal cancer. The dynamics of tumor initiation remain unknown, but the interaction between neoplastic cells and the immune system is believed to play a critical role in this process.

NATURE COMMUNICATIONS (2022)

添加到收藏夹

Article Oncology

Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics

Jill Gallaher, Maximilian Strobl, Jeffrey West, Robert Gatenby, Jingsong Zhang, Mark Robertson-Tessi, Alexander R. A. Anderson

Summary: This study proposed a framework for estimating features of metastases through tumor response dynamics in patients with metastatic castration-resistant prostate cancer undergoing adaptive androgen deprivation treatment. The size of metastases, the proportion of drug-resistant cells, and the cell turnover rate were found to affect the treatment outcomes. The number of metastases, on the other hand, did not have an impact on the treatment cycle times.

CANCER RESEARCH (2023)

添加到收藏夹

Article Biology

Spatial cumulant models enable spatially informed treatment strategies and analysis of local interactions in cancer systems

Sara Hamis, Panu Somervuo, J. Arvid Agren, Dagim Shiferaw Tadele, Juha Kesseli, Jacob G. G. Scott, Matti Nykter, Philip Gerlee, Dmitri Finkelshtein, Otso Ovaskainen

Summary: Spatial cumulant models (SCMs) provide a mathematical framework to accurately describe the dynamics of theoretical cancer cell populations generated by spatio-temporal point processes (STPPs). By using SCMs, we can study cell-cell interactions and design more effective treatment strategies to inhibit population growths.

JOURNAL OF MATHEMATICAL BIOLOGY (2023)

添加到收藏夹

Article Oncology

Exploiting convergent phenotypes to derive a pan-cancer cisplatin response gene expression signature

Jessica A. A. Scarborough, Steven A. A. Eschrich, Javier Torres-Roca, Andrew Dhawan, Jacob G. G. Scott

Summary: Precision medicine has potential in cancer treatment, but mainly focuses on tumors with actionable mutations. Gene expression signatures can expand precision medicine by predicting response to traditional chemotherapy agents, regardless of mutational status. This study presents a new signature extraction method that can produce consensus signatures predictive of response to over 200 chemotherapeutic drugs. The study demonstrates the use of this method in predicting cisplatin response and its alignment with clinical trends in tumor samples.

NPJ PRECISION ONCOLOGY (2023)

添加到收藏夹

Editorial Material Oncology

Evolutionary Dynamics and Intermittent Therapy for Metastatic Cancers

Jad Chahoud, Alexander R. A. Anderson, Jingsong Zhang, Joel Brown, Robert A. Gatenby

JOURNAL OF CLINICAL ONCOLOGY (2023)

添加到收藏夹

Article Engineering, Biomedical

Radio-immune response modelling for spatially fractionated radiotherapy

Young-Bin Cho, Nara Yoon, John H. Suh, Jacob G. Scott

Summary: A mathematical model of immune response during and after radiation therapy is proposed, revealing the impact of radiation therapy on immune reaction. The model reveals that the heterogeneous dose distribution in spatially fractionated radiotherapy has a significant effect on tumor cell killing. The model is validated on mice and a sarcoma patient.

PHYSICS IN MEDICINE AND BIOLOGY (2023)

添加到收藏夹

Article Engineering, Biomedical

Graph 'texture' features as novel metrics that can summarize complex biological graphs

R. Barker-Clarke, D. T. Weaver, J. G. Scott

Summary: This study aims to derive analogous texture features for graphs and networks and demonstrate their usefulness in summarizing graphs, aiding comparative graph studies, classifying biological graphs, and detecting dysregulation in cancer. The co-occurrence matrices for graphs are generated to obtain novel graph 'texture' features that reflect graph structure and node label distributions. These texture metrics are sensitive to discretization parameters and noise and can be used to classify cell line expression with high accuracy.

PHYSICS IN MEDICINE AND BIOLOGY (2023)

添加到收藏夹

Article Computer Science, Artificial Intelligence

Mistic: An open-source multiplexed image t-SNE viewer

Sandhya Prabhakaran, Chandler Gatenbee, Mark Robertson-Tessi, Jeffrey West, Amer A. Beg, Jhanelle Gray, Scott Antonia, Robert A. Gatenby, Alexander R. A. Anderson

Summary: Understanding the complex ecology of tumor tissue and its cellular and microenvironment components is crucial for translational research, and the generation and analysis of multiplexed images from patient samples play a key role in facilitating this understanding. Mistic is an open-source multiplexed image t-SNE viewer that allows simultaneous viewing of multiple 2D images for an overall visual preview of the dataset.

PATTERNS (2022)

添加到收藏夹

Meeting Abstract Oncology

Integrating mathematical modelling and wet-lab experiments to examine the scope for adaptive treatment scheduling of PARP inhibitors in ovarian cancer

Maximilian Strobl, Mehdi Damaghi, Alexandra Martin, Samantha Byrne, Mark Robertson-Tessi, Robert Gatenby, Robert Wenham, Philip Maini, Alexander R. A. Anderson

CANCER RESEARCH (2022)

添加到收藏夹

Article Medicine, Research & Experimental

Spatial structure impacts adaptive therapy by shaping intra-tumoral competition

Maximilian A. R. Strobl, Jill Gallaher, Jeffrey West, Mark Robertson-Tessi, Philip K. Maini, Alexander R. A. Anderson

Summary: This theoretical study investigates the intra-tumoral competition during adaptive therapy and finds that adaptive therapy is superior to aggressive treatment in suppressing resistance. The study reveals that competition among resistant cells plays a crucial role in adaptive therapy in solid tumors.

COMMUNICATIONS MEDICINE (2022)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.